SGS is caused by mutations in SKI, and both SMAD-mediated and non-SMAD-mediated TGF-β signaling has been reported to be increased in primary dermal fibroblasts from SGS patients (Doyle et al., 2012). The gene discussed is TGFB1; the disease is Shprintzen-Goldberg syndrome.